"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A trial of targeted drugs for chronic myeloid leukaemia when treatment has stopped working (TASTER)
This trial was for people with chronic myeloid leukaemia. It looked at adding a targeted drug to the targeted drug people were already taking.
It was open to people with chronic myeloid leukaemia (CML):
- whose treatment had stopped working
- that had the
Philadelphia chromosomeand is in the chronic phase stage or accelerated phase stage
Cancer Research UK supported this trial.
More about this trial
When this trial was done, doctors could treat chronic myeloid leukaemia (CML) with one of the following:
Sometimes these drugs stop working. So researchers were looking for other drugs to help people in this situation. In this trial, they are looked at other TKI's
The aims of this trial were to find out:
- how well adding a newer drug works
- what the side effects are
- how it affects
quality of life
Summary of results
There aren't any results available for this trial. This was because it closed earlier than planned as it was difficult to recruit patients to take part.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mhairi Copland
Cancer Research UK
University of Glasgow
NHS Greater Glasgow and Clyde
This is Cancer Research UK trial number CRUK/17/016.